Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Assets Average (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Assets Average for 11 consecutive years, with $94.7 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 132.58% to $94.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $94.7 million through Dec 2025, up 132.58% year-over-year, with the annual reading at $64.1 million for FY2025, 160.05% up from the prior year.
  • Assets Average hit $94.7 million in Q4 2025 for vTv Therapeutics, up from $63.0 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $94.7 million in Q4 2025 to a low of $13.0 million in Q4 2023.
  • Historically, Assets Average has averaged $34.5 million across 5 years, with a median of $30.1 million in 2023.
  • Biggest five-year swings in Assets Average: crashed 62.27% in 2023 and later soared 213.89% in 2024.
  • Year by year, Assets Average stood at $28.5 million in 2021, then rose by 20.82% to $34.4 million in 2022, then plummeted by 62.27% to $13.0 million in 2023, then skyrocketed by 213.89% to $40.7 million in 2024, then soared by 132.58% to $94.7 million in 2025.
  • Business Quant data shows Assets Average for VTVT at $94.7 million in Q4 2025, $63.0 million in Q3 2025, and $29.2 million in Q2 2025.